Biotech + IPO Architect: A New Entrepreneurial Paradigm in the AI Era
Traditional drug discovery models are no longer sufficient for today's complexities. The AI era demands a new archetype: the Industry + IPO Architect. Transcending the roles of traditional CFOs or consultants, this model uses "Exit-by-Design" to bridge science and capital.
Time & Location
Feb 07, 2026, 3:00 PM – 5:00 PM
Cordx, 8940 Kenamar Dr, San Diego, CA 92121, USA
About the event
Part 1: Basic Information & Logistics
Join us in person if possible! We also provide a Zoom option for remote attendees. The Zoom link will be sent via email after registration.
Featured Speaker: Dr. Tao Ke – AI Pioneer & Global Strategy Expert Dr. Ke is a veteran strategist in the AI field with 26 years of hands-on experience in global strategy, M&A, financing, and AI business models. He is a premier consultant for corporate globalization and capital operations. Having entered the industry during the early "AI winters," he has remained deeply committed to the field ever since.
Academic Background: Dr. Ke earned his Ph.D. in Computational Biochemistry from MIT in 1998. He is a pioneer in integrating AI and data analytics with industrial upgrading.
Professional Track Record: He has held core management roles at top-tier consulting firms, including McKinsey, Bain, and Accenture, where he was deeply involved in strategic planning, technological innovation,…